Urology · Davenport, IA
NPI
1356344287
Since 2005
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
3319 Spring Street, Urological Assc PC
Davenport, IA, 52807
Phone (563) 359-1641
Groups this clinician bills Medicare through
Medicare paid, 2024
$771K
28,066 services
Medicare patients, 2024
693
Average age 76
Drug cost, 2024
$11.0M
2,896 prescriptions
Company payments, 2025
$385
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ghasoub Harb was code J0897 (injection, denosumab, 1 mg), 13,800 times for 64 patients. In total Ghasoub Harb billed 28,066 services in 103 codes, and Medicare paid $771K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-09-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 13,800 | 64 | $20.63 | $285K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 3,110 | 29 | $0.10 | $314 |
| J9030 Bcg live intravesical instillation, 1 mg | Office | 2,634 | 20 | $2.22 | $5,854 |
| 87798 Infectious Agent Detection by DNA/RNA | Office | 1,235 | 85 | $34.39 | $42K |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 690 | 75 | $139.97 | $97K |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 670 | 92 | $43.66 | $29K |
| 36415 Venipuncture Blood Collection | Office | 596 | 282 | $8.56 | $5,100 |
| 81001 Clinical Chemistry | Office | 485 | 329 | $3.10 | $1,506 |
| 84153 Clinical Chemistry | Office | 480 | 244 | $17.90 | $8,593 |
| 99214 Office E&M - Established | Office | 363 | 231 | $81.72 | $30K |
| 99213 Office E&M - Established | Office | 343 | 251 | $58.83 | $20K |
| 80053 Clinical Chemistry | Office | 300 | 113 | $10.25 | $3,074 |
| 87801 Infectious Agent Detection by DNA/RNA | Office | 285 | 85 | $68.80 | $20K |
| 87481 Infectious Agent Detection by DNA/RNA | Office | 285 | 85 | $34.39 | $9,800 |
| 96372 Injection Administration | Office | 190 | 100 | $10.14 | $1,926 |
By year: 2022 $677K for 31,334 services; 2023 $709K for 30,194 services; 2024 $771K for 28,066 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87798 Infectious Agent Detection by DNA/RNA | 1,235 | 85 | $34.39 | $42K |
| 36415 Venipuncture Blood Collection | 596 | 282 | $8.56 | $5,100 |
| 81001 Clinical Chemistry | 485 | 329 | $3.10 | $1,506 |
| 84153 Clinical Chemistry | 480 | 244 | $17.90 | $8,593 |
| 80053 Clinical Chemistry | 300 | 113 | $10.25 | $3,074 |
| 87481 Infectious Agent Detection by DNA/RNA | 285 | 85 | $34.39 | $9,800 |
| 87801 Infectious Agent Detection by DNA/RNA | 285 | 85 | $68.80 | $20K |
| 80048 Clinical Chemistry | 116 | 99 | $8.23 | $955 |
| 85025 Blood Count | 101 | 65 | $7.61 | $769 |
| 87496 Infectious Agent Detection by DNA/RNA | 95 | 85 | $34.39 | $3,267 |
Medicare prescription drug claims, 2024
In 2024, the drug Ghasoub Harb prescribed most often to Medicare patients was Tamsulosin Hcl, with 384 prescriptions and refills. In total Ghasoub Harb wrote 2,896 Medicare prescriptions that cost $11.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 384 | 1,033 | 148 | $6,671 |
| Erleada Apalutamide | 343 | 356 | 37 | $5.0M |
| Xtandi Enzalutamide | 235 | 235 | 36 | $3.0M |
| Dutasteride Generic | 211 | 583 | 72 | $7,204 |
| Prednisone Generic | 190 | 203 | 27 | $1,170 |
| Orgovyx Relugolix | 182 | 182 | 24 | $503K |
| Abiraterone Acetate Generic | 178 | 184 | 24 | $155K |
| Doxazosin Mesylate Generic | 169 | 495 | 69 | $2,617 |
| Nubeqa Darolutamide | 156 | 156 | 18 | $2.0M |
| Finasteride Generic | 155 | 432 | 49 | $1,827 |
| Doxycycline Monohydrate Generic | 75 | 89 | 62 | $1,504 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 52 | 114 | 21 | $1,242 |
| Bicalutamide Generic | 51 | 85 | 28 | $1,308 |
| Myrbetriq Mirabegron | 51 | 96 | 19 | $43K |
| Cephalexin Generic | 44 | 62 | 19 | $419 |
Brand drugs: - claims; generic drugs: 1,865 claims; opioid claims: 35.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ghasoub Harb $385 ($385 in general payments such as food, travel and fees) from 4 companies. The largest payer was Tolmar, Inc. with $120.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.